Ginascol John F 4
4 · ABBOTT LABORATORIES · Filed Oct 27, 2021
Insider Transaction Report
Form 4
Ginascol John F
Executive Vice President
Transactions
- Exercise/Conversion
Option (right to buy)
2021-10-27−45,709→ 0 totalExercise: $47.00From: 2018-02-20Exp: 2025-02-19→ Common Shares (45,709 underlying) - Tax Payment
Common shares without par value
2021-10-27$128.13/sh−29,588$3,791,110→ 113,674 total - Exercise/ConversionSwap
Common shares without par value
2021-10-27$47.00/sh+45,709$2,148,323→ 143,262 total
Footnotes (1)
- [F1]Stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.